Last reviewed · How we verify
Valsartan and Sacubitril
Valsartan and Sacubitril is a Small molecule drug developed by University Hospital Ostrava. It is currently FDA-approved. Also known as: Entresto, ATC C09DX04.
At a glance
| Generic name | Valsartan and Sacubitril |
|---|---|
| Also known as | Entresto, ATC C09DX04 |
| Sponsor | University Hospital Ostrava |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction
- Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy (NA)
- Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets (PHASE1)
- Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3 (PHASE4)
- Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (PHASE1, PHASE2)
- A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan
- A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction (PHASE1)
- A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Valsartan and Sacubitril CI brief — competitive landscape report
- Valsartan and Sacubitril updates RSS · CI watch RSS
- University Hospital Ostrava portfolio CI
Frequently asked questions about Valsartan and Sacubitril
What is Valsartan and Sacubitril?
Valsartan and Sacubitril is a Small molecule drug developed by University Hospital Ostrava.
Who makes Valsartan and Sacubitril?
Valsartan and Sacubitril is developed and marketed by University Hospital Ostrava (see full University Hospital Ostrava pipeline at /company/university-hospital-ostrava).
Is Valsartan and Sacubitril also known as anything else?
Valsartan and Sacubitril is also known as Entresto, ATC C09DX04.
What development phase is Valsartan and Sacubitril in?
Valsartan and Sacubitril is FDA-approved (marketed).
Related
- Manufacturer: University Hospital Ostrava — full pipeline
- Also known as: Entresto, ATC C09DX04
- Compare: Valsartan and Sacubitril vs similar drugs
- Pricing: Valsartan and Sacubitril cost, discount & access